The most important benefit of participating in a clinical trial is that patients get early access to potentially new and successful treatments or screenings before the general public. (Karmanos Cancer ...
Success rates in phase II and phase III clinical trials are recognized as two of the most powerful drivers of overall efficiency in drug development (Nat. Rev. Drug Discov. 23, 656–657; 2024). With ...
ASCO prioritizes access to patient-centered cancer research in its strategic plan. ASCO and the Association of Cancer Care Centers (ACCC) jointly concluded that clinical trials are an integral ...